NCT07417722

Brief Summary

Carpal tunnel syndrome is a common condition caused by pressure on a nerve at the wrist. It can lead to pain, numbness, weakness, and difficulty using the hand during daily activities. In this clinical trial, researchers will study a non-drug treatment approach for people with carpal tunnel syndrome. Participants will be randomly assigned to one of two groups. One group will receive a wrist splint and a home exercise program. The other group will receive peloidotherapy in addition to the same splint and exercise program. Pain, hand function, daily activities, quality of life, hand strength, and ultrasound findings of the median nerve will be evaluated before treatment, at the end of treatment, and during follow-up periods. The goal of this study is to determine whether adding peloidotherapy to wrist splint and a home exercise program provides additional benefits in reducing pain and improving hand function in people with carpal tunnel syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

February 4, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

3 months

First QC Date

February 4, 2026

Last Update Submit

February 10, 2026

Conditions

Keywords

Carpal Tunnel SyndromePeloidotherapyMedian Nerve Cross-Sectional AreaHand Grip StrengthFunctional DisabilityPain

Outcome Measures

Primary Outcomes (1)

  • Boston Carpal Tunnel Questionnaire (BCTQ)

    Symptom severity and functional status measured using the Boston Carpal Tunnel Questionnaire (BCTQ), which includes Symptom Severity and Functional Status subscales. Each item is scored from 1 to 5 and subscale scores are calculated as the mean of item scores. Higher scores indicate worse symptoms and functional limitation.

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)

Secondary Outcomes (5)

  • Median Nerve Cross-Sectional Area

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), and 3-month follow-up (week 15).

  • QuickDASH Score

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)

  • Visual Analog Scale for Pain at Rest

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)

  • Visual Analog Scale for Pain During Activity

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)

  • Visual Analog Scale for Night Pain

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)

Other Outcomes (3)

  • Short Form-12 Health Survey Scores (SF-12)

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), and 3-month follow-up (week 15).

  • DN4 Neuropathic Pain Questionnaire Score

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), and 3-month follow-up (week 15).

  • Hand Grip Strength

    Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), and 3-month follow-up (week 15).

Study Arms (2)

Non-Peloid Therapy Group

ACTIVE COMPARATOR

Participants receive treatment consisting of wrist splinting and a structured home exercise program. No peloid therapy is administered.

Device: Wrist SplintOther: Home Exercise Program

Peloid Therapy Group

EXPERIMENTAL

Participants receive wrist splinting and a structured home exercise program in addition to peloid therapy. Peloid therapy is applied at 45 °C for 30 minutes per session, for a total of 15 sessions.

Other: Peloid TherapyDevice: Wrist SplintOther: Home Exercise Program

Interventions

Peloid therapy is applied at 45 °C for 30 minutes per session, for a total of 15 sessions.

Peloid Therapy Group

Participants used a neutral-position wrist splint as part of conservative treatment for carpal tunnel syndrome.

Non-Peloid Therapy GroupPeloid Therapy Group

Participants performed a standardized home exercise program including median nerve gliding exercises and tendon gliding exercises for the wrist and hand.

Non-Peloid Therapy GroupPeloid Therapy Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with mild or mild-to-moderate carpal tunnel syndrome confirmed by electromyography (EMG)
  • Presence of clinical symptoms for at least 3 months
  • Age 18 years and older
  • No limitation in wrist joint range of motion

You may not qualify if:

  • Cervical radiculopathy
  • Polyneuropathy
  • Pregnancy
  • Presence of underlying metabolic diseases (diabetes mellitus, inflammatory rheumatic diseases, thyroid disorders)
  • Presence of hand osteoarthritis
  • Previous wrist or hand surgery
  • Severe carpal tunnel syndrome confirmed by electromyography (EMG)
  • Thenar muscle atrophy
  • Corticosteroid injection for carpal tunnel syndrome or use of a wrist splint within the last 6 months
  • History of malignancy
  • Receipt of peloid therapy or any physical therapy modality for carpal tunnel syndrome within the last 6 months
  • Contraindications to peloid therapy (impaired skin integrity or active infection at the application site)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziosmanpaşa Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (4)

  • Tezcan S, Ulu Ozturk F, Uslu N, Nalbant M, Umit Yemisci O. Carpal Tunnel Syndrome: Evaluation of the Effects of Low-Level Laser Therapy With Ultrasound Strain Imaging. J Ultrasound Med. 2019 Jan;38(1):113-122. doi: 10.1002/jum.14669. Epub 2018 Jun 11.

    PMID: 29892976BACKGROUND
  • Yigit F, Ordahan B. Effects of high-intensity laser therapy on pain, functional status, hand grip strength, and median nerve cross-sectional area by ultrasonography in patients with carpal tunnel syndrome. Lasers Med Sci. 2023 Oct 31;38(1):248. doi: 10.1007/s10103-023-03913-z.

    PMID: 37906312BACKGROUND
  • Metin Okmen B, Kasapoglu Aksoy M, Gunes A, Eroksuz R, Altan L. Effectiveness of PELOID therapy in carpal tunnel syndrome: A randomized controlled single blind study. Int J Biometeorol. 2017 Aug;61(8):1403-1410. doi: 10.1007/s00484-017-1317-1. Epub 2017 Feb 16.

    PMID: 28210859BACKGROUND
  • Sirin Ahisha B, Akkaya Ari S, Paker N, Kesiktas N, Barut Y. Comparison of the efficacy of peloid therapy and paraffin treatment in carpal tunnel syndrome. Int J Biometeorol. 2025 Aug;69(8):1957-1967. doi: 10.1007/s00484-025-02941-4. Epub 2025 May 13.

    PMID: 40358708BACKGROUND

MeSH Terms

Conditions

Carpal Tunnel SyndromePain

Interventions

Mud Therapy

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BalneologyTherapeutics

Study Officials

  • Ebru Yılmaz Yalçınkaya, MD

    Department of Physical Medicine and Rehabilitation, Gaziosmanpaşa Training and Research Hospital, Istanbul, Turkey

    PRINCIPAL INVESTIGATOR
  • Serap Seringeç Karabulut, MD

    Department of Medical Ecology and Hydroclimatology, Gaziosmanpaşa Training and Research Hospital, Istanbul, Turkey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor was blinded to group allocation. No other participants or study personnel were masked.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to one of two parallel groups. One group received a wrist splint and a home exercise program, while the other group received peloidotherapy in addition to the same wrist splint and home exercise program. Participants remained in their assigned group throughout the study.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician in Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

February 4, 2026

First Posted

February 18, 2026

Study Start

June 1, 2025

Primary Completion

September 11, 2025

Study Completion

January 15, 2026

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to ethical and legal restrictions related to patient confidentiality and institutional policies.

Locations